AFT Pharmaceuticals

[Minimoke]

Agreed. I never said that ESG or anti-ESG statements from companies (i.e. no matter which side of the polarised world we live in one supports) add any value. Not for SML, not for HGH and not for AFT.

I was just surprised that you indicated this anti-woke statement from AFT makes them "investable"- or did I misread you post?

Anybody who wants to assess the quality of their management just needs to look at their historic performance ... and when you say that other companies suffered as well during that time I invite you to compare AFT over the last decade with (e.g.) FPH or Ebos (both in the same industry, and both nearly quadrupled their SP over the last decade. Tough times? Hmm ...). AFT did not even manage to capitalise on the Covid boost, I guess how inept is this for a medical company selling (well, mainly) painkillers? I heard painkillers have been in demand during Covid - and AFT didn't even manage to capitalise on that.

So - they worked in an industry just splashing in money over the last 5 years or so - and poor inept AFT  missed out. Is this how you recognise investable companies? Did they change anything since this disastrous performance other than slinging anti woke slogans?

You misread my post. My opening words were 'First something ...". I didn't think I needed to emphasise the word "something". It is one thing. Not everything. Which is why I went on to post metrics on performance.

I consider companies who over indulge in DEI as uninvesibale - and I listed two companies as examples. I could have added the Warehouse and a pile more. Its a very clear sign to me they don't actually have shareholders best interests at heart. Its a rule of thumb I use. Others can choose other selection criteria.

My post was about today's results. It wasn't a history lesson. Nor was it an exercise in comparing one investment opportunity with another. As I say - it was a post based on the actual results achieved in the past year.

At face value it looks, to me "investable" especially if I choose to compare with today's other announcement MFB.

But it should go without saying (but obviously I need to) you shouldn't form an investment decision firstly of some random post on an internet forum . Nor without doing more due diligence.

And since when is hiring on merit ("best person") "antiwoke" I find that quite bizarre. Any company that sets forth to hire the best people are eminently investible (all other things considered) because they are setting down solid business foundations.

[KW]

Ibuprofen was not recommended for Covid symptoms as it was believed to exacerbate the condition.  A bit of research goes a long way.
https://www.bmj.com/content/368/bmj.m1086

And despite this advice probably being completely useless and untrue (like all the other Covid advice), people at the time probably believed it. 

[Minimoke]

......

So - they worked in an industry just splashing in money over the last 5 years or so - and poor inept AFT  missed out. Is this how you recognise investable companies? Did they change anything since this disastrous performance other than slinging anti woke slogans?

A bit slack of me I know. But I can't be posting every day.

Consequently I missed posting the ACC on market purchases of 1,152,018 shares for $2,995,246.80 between 14 Jan and 14 may this year. Which makes them a substantial holder with 6.047%

Looking more investable than not to me.

[Minimoke]

On the other hand ... market takes - following these results - a huge leap upwards. At time of writing already 164 shares changed hands at 10am for $3 each and 2 (two) shares subsequently at 10:39 pushing the SP into the stratosphere: $3.04!

Somebody prepared to gamble the farm?

You might want to give the market time to wake up, get out of bed and digest the news.

Market closed up 4.67% to $3.14

[winner (n)]

Just as AFT share price was looking like going somewhere its heading back to 3 bucks again

[BlackPeter]

Ah well, not really a company I follow (anymore), but remember the talk of their CEO at the NZSA many years ago. Often a good sign that the company is desperate to find new shareholders - and cheap talk in front of potential shareholders (vs. demonstrating performance) is their last resort.

Just saw this article in the business desk:

https://businessdesk.co.nz/markets/announcements-generated-by-ai/aft-pharmaceuticals-expects-2m-operating-loss

(probably paywalled and lacking any new information (AI generated) not worthwhile to subscribe.

So, a loss it is (first HY) ... thanks to all these new markets they proudly touted around for the last decade, which all add to their cost but not to their earnings. What a surprise. But anyway - the second HY will make it all good again. Where have we heard that before?

But hey - just looking at their long term trend - their share just reached 2016 level, didn't it? ... and as far as I can see only in two years a tiny dividend paid: 1.1 cents per share in 2023 and 1.6 cents in 2024. Just wondering what they will pay after this years loss?

You cannot view this attachment.

I guess based on FA it was always highly likely that this company will be a disappointer (a me-too without new ideas and without any worthwhile IP), but for sure - any good trader might have made good coin. April 2019 to April 2020 was great for traders, and the rest of the time was great for shorters.

[winner (n)]

Peter ..AFT not too bad ...they've trebled revenues since 2016

That's pretty good

[Basil]

I'm with BP on this one.  The IP of this company is ostensibly nothing more than a brand and has no substance behind it.  As he has quite correctly warned several times before, it's very inexpensive to combine generic brand paracetamol and ibuprofen together to get exactly the same effect for a fraction of the price.    Pretty ugly looking chart.  Shares have done a round trip to nowhere in the last 9 years and in the last 4 have been in a steady decline. Noting also the pathetic dividend yield of just 0.54% (off Jarden website).

[winner (n)]

Market spoken after that announcement last week

Getting close to 52 week low

[winner (n)]

New 52 week low at $2.56 today

Long way from 52 week high of $3.58

Reaction to possible loss been brutal

Are they seen as being exposed to what Trump might get up to?

Getting close to take a punt ..it's Cup Week after all

[BlackPeter]

New 52 week low at $2.56 today

Long way from 52 week high of $3.58

Reaction to possible loss been brutal

Are they seen as being exposed to what Trump might get up to?

Getting close to take a punt ..it's Cup Week after all

Might be risky. Not everything which drops is going to bounce. What do you see in their fundamentals tempting you?

[winner (n)]

Jeez, another down day to close at $2.48

Multi year low in spite of all those positive announcements over the last five years

[winner (n)]

New Year's newsletter seem rather long winded so didn't read but got AI to summarise -

AFT Pharmaceuticals New Year Letter to Investors

AFT Pharmaceuticals aims for record sales exceeding $200M in FY25, targeting $300M by FY27.

Key growth strategies include expanding product portfolios in Australia, New Zealand, USA, Canada, and South Africa.

New product launches in Europe and China are underway.

R&D pipeline includes 24 hospital injectables and various topical treatments.

E-commerce initiatives are progressing, with significant sales growth.

Financial management remains cautious, focusing on geographic expansion and product introduction

All this might happen by 2026

[BlackPeter]

New Year's newsletter seem rather long winded so didn't read but got AI to summarise -

AFT Pharmaceuticals New Year Letter to Investors

AFT Pharmaceuticals aims for record sales exceeding $200M in FY25, targeting $300M by FY27.

Key growth strategies include expanding product portfolios in Australia, New Zealand, USA, Canada, and South Africa.

New product launches in Europe and China are underway.

R&D pipeline includes 24 hospital injectables and various topical treatments.

E-commerce initiatives are progressing, with significant sales growth.

Financial management remains cautious, focusing on geographic expansion and product introduction

All this might happen by 2026

I think the down channel is even without AI support visible.

Anyway - I plan to aim in 2026 with my pellet gun at the moon. Will I hit it, though? Same thing.

[winner (n)]

AFT keep churning out investor updaters but the posivity never seems to boost the share prices ...always seems to fall back to $260/$280 ,...and currently near to multi year low

Forbsr had a price target of $4.60 not that long ago but AFT remains unloved